The impact of anti-HBc positivity on clinical outcomes and treatment response in immune thrombocytopenia
These findings suggest that anti-HBc positivity may be associated with a more severe disease course and reduced treatment efficacy in ITP, highlighting the importance of assessing hepatitis B serological markers when managing ITP patients.
Authors
- Özlem Beyler (ORCID: https://orcid.org/0000-0002-2032-8877)
- Cengiz Demır (ORCID: https://orcid.org/0000-0001-9856-184X)
- Ali Doğan (ORCID: https://orcid.org/0000-0003-0207-3505)
Institutions
- Van Yüzüncü Yıl Üniversitesi (TR)
- Üsküdar University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Wiener klinische Wochenschrift
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1007/s00508-025-02563-1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00